John Toomey Appointed Vice President of Growth and Innovation of RMS Medical Products

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

John Toomey
John Toomey

John Toomey has been appointed to the newly created position of Vice President of Growth and Innovation of RMS Medical Products. John Toomey brings to RMS over 30 years of medical device industry experience as an executive, patent officer, inventor, board member, and advisor.

Mr. Toomey will be responsible for research and development, product innovation, and business development, and integrating these capabilities across the enterprise. He will also play a key role in building a robust IP platform.

Mr. Toomey has held leadership roles at numerous medical device companies, including Pneuma Systems Corporation, Validose, Inc., Halkey-Roberts Corporation, Smith’s Medical, Inc., and CR Bard (acquired by Becton Dickinson). He also founded 2ME Mgmt Consultancy, LLC, which specialized in developing latent market opportunities and solving project, regulatory and IP challenges in the medical device space.

Mr. Toomey received his BS from Allegheny College, MBA from the Marshall School of Business at the University of Southern California, and JD from Thomas Jefferson School of Law.

Mr. Toomey holds 24 U.S. and foreign patents.

“Product innovation is a key driver of our previously announced strategic plan to become the preferred drug delivery partner for specific infusion therapies in select markets,” said Don Pettigrew, President and CEO of RMS Medical. “John has an impressive track record of developing and commercializing value-creating medical device solutions, and we are confident in his ability to help RMS pioneer new infusion products and applications. John is the latest in a series of strategic hires and appointments that we believe have positioned RMS Medical for continued growth and an elevated industry profile.”

“I am excited to join the team at RMS Medical at this important stage of development,” said Mr. Toomey. “The Company has a well-respected family of infusion therapy products, is addressing growing end markets, and is led by a seasoned and accomplished group of executives. I look forward to working with the team and building upon RMS Medical’s patient-focused platform.”

 

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.